Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms by Histologic Type × Lenalidomide × 30 days × Clear all

Sponsor

Conditions

Multiple Myeloma 36 Lymphoma, Follicular 13 Lymphoma, Large B-Cell, Diffuse 11 Lymphoma 7 Lymphoma, Non-Hodgkin 6 Recurrence 5 Lymphoma, B-Cell, Marginal Zone 5 Lymphoma, Mantle-Cell 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Neoplasms, Plasma Cell 3 Neoplasms 3 Smoldering Multiple Myeloma 2 Myelodysplastic Syndromes 2 Leukemia, Myelomonocytic, Chronic 2 Hodgkin Disease 2 Burkitt Lymphoma 2 Waldenstrom Macroglobulinemia 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Paraproteinemias 1 Neuroblastoma 1 Neoplasm, Residual 1 Lymphoproliferative Disorders 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, B-Cell 1 Leukemia, Hairy Cell 1 Intraocular Lymphoma 1 Immunoproliferative Disorders 1 HTLV-I Infections 1 GATA2 Deficiency 1 Anemia, Refractory, with Excess of Blasts 1

Interventions

trametinib 1 pralsetinib 1 ponatinib 1 pembrolizumab 1 fludarabine phosphate 1 fludarabine 1 durvalumab 1 dabrafenib 1 Whole-Body Irradiation 1 Tacrolimus 1 Peripheral Blood Stem Cell Transplantation 1 Pemetrexed 1 Patient Reported Outcome Measures 1 Paclitaxel 1 Mycophenolic Acid 1 Mesna 1 Melphalan 1 Immunotherapy 1 Gemcitabine 1 Cyclophosphamide 1 Cisplatin 1 Carboplatin 1 Busulfan 1 Bone Marrow Transplantation 1 Biopsy 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡